How Will Patents Impact the Commercialization of Stem Cell Therapeutics?
October 17, 2007
Foley Partner Michele Simkin and former Foley attorney Todd Spalding byline “How Will Patents Impact the Commercialization of Stem Cell Therapeutics,” appeared in the October issue of the Journal of Pharmaceutical Innovation.
Author(s)
Related Insights
June 26, 2025
Energy Current
EPA Signals Approval of Texas’ Class VI Injection Well Primacy: Streamlining Carbon Capture and Climate Action
In a significant move for environmental policy and energy innovation, the U.S. Environmental Protection Agency (EPA) has proposed to…
June 26, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…
June 26, 2025
Foley Career Perspectives
Foley Pride Month Program: Generational Experiences of LGBTQIA+ Attorneys
Continuing our celebration of Pride Month, Foley & Lardner presented an engaging discussion with four of our LGBTQ+ attorneys.